Literature DB >> 15177284

Cloning, expression, and purification of the 27 kDa (MPT51, Rv3803c) protein of Mycobacterium tuberculosis.

B Ramalingam1, Alain R Baulard, Camille Locht, P R Narayanan, Alamelu Raja.   

Abstract

A limited number of proteins of Mycobacterium tuberculosis have been characterized so far for their use as potential candidates for diagnosis and vaccine studies. This study was aimed at cloning, expression, and purification of a 27 kDa protein (otherwise known as the MPT51 or Rv3803c protein) of M. tuberculosis. The Rv3803c gene was PCR amplified using primers that contain specific restriction sites. The amplified product was inserted initially into pTOPO and then sub-cloned into pET15b and pET24d vectors, such that the recombinant protein is predicted to contain an N-terminal or a C-terminal histidine tag, respectively. The recombinant plasmids were introduced into Escherichia coli BL21 (DE3) and the recombinant proteins were purified from the cytosolic fractions of the E. coli sonicates by nickel-NTA chromatography. The purity, molecular mass, and the conformation of the proteins were determined by high performance liquid chromatography (HPLC), matrix assisted laser desorption-ionization-time-of-flight (MALDI-TOF), and circular dichroism (CD) studies, respectively. The purified proteins were found to be immunogenic and useful for immunodiagnostic studies of tuberculosis by enzyme linked immunosorbent assay (ELISA), with a sensitivity of 71% and specificity of 95%.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177284     DOI: 10.1016/j.pep.2004.01.016

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  7 in total

1.  Mycobacterium tuberculosis malate synthase- and MPT51-based serodiagnostic assay as an adjunct to rapid identification of pulmonary tuberculosis.

Authors:  Jacqueline M Achkar; Yuxin Dong; Robert S Holzman; John Belisle; Irene S Kourbeti; Tsering Sherpa; Rany Condos; William N Rom; Suman Laal
Journal:  Clin Vaccine Immunol       Date:  2006-11

2.  Specific T cell induction using iron oxide based nanoparticles as subunit vaccine adjuvant.

Authors:  Lázaro Moreira Marques Neto; Nicholas Zufelato; Ailton Antônio de Sousa-Júnior; Monalisa Martins Trentini; Adeliane Castro da Costa; Andris Figueiroa Bakuzis; André Kipnis; Ana Paula Junqueira-Kipnis
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

3.  Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51.

Authors:  Ban Al-Sayyed; Sajida Piperdi; Xinni Yuan; Anping Li; Gurdyal S Besra; William R Jacobs; Arturo Casadevall; Aharona Glatman-Freedman
Journal:  Tuberculosis (Edinb)       Date:  2007-09-19       Impact factor: 3.131

4.  Potential of High-Affinity, Slow Off-Rate Modified Aptamer Reagents for Mycobacterium tuberculosis Proteins as Tools for Infection Models and Diagnostic Applications.

Authors:  Theresa M Russell; Louis S Green; Taylor Rice; Nicole A Kruh-Garcia; Karen Dobos; Mary A De Groote; Thomas Hraha; David G Sterling; Nebojsa Janjic; Urs A Ochsner
Journal:  J Clin Microbiol       Date:  2017-08-09       Impact factor: 5.948

5.  Evaluation of 5 Novel protein biomarkers for the rapid diagnosis of pulmonary and extra-pulmonary tuberculosis: preliminary results.

Authors:  Amit Singh; Anil Kumar Gupta; Krishnamoorthy Gopinath; Pawan Sharma; Sarman Singh
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

6.  Comparison of whole blood and PBMC assays for T-cell functional analysis.

Authors:  Anbarasu Deenadayalan; Prabhavathi Maddineni; Alamelu Raja
Journal:  BMC Res Notes       Date:  2013-03-27

7.  Cloning, Expression, and Refolding of PPE17 Protein of Mycobacterium Tuberculosis as a Promising Vaccine Candidate.

Authors:  Adel Najafi; Mohsen Tafaghodi; Mojtaba Sankian; Yousef Amini; Kiarash Ghazvini
Journal:  Iran J Med Sci       Date:  2019-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.